Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages

被引:43
|
作者
Ewart, GD
Nasr, N
Naif, H
Cox, GB
Cunningham, AL
Gage, PW
机构
[1] Australian Natl Univ, Biotron Ltd, Canberra, ACT 2601, Australia
[2] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia
[3] Westmead Millenium Inst, Westmead, NSW 2145, Australia
关键词
D O I
10.1128/AAC.48.6.2325-2330.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We report that the amiloride analogues 5-(N,N'-hexamethylene)amiloride and 5-(N,N'-dimethyl)amiloride inhibit, at micromolar concentrations, the replication of human immunodeficiency virus type 1 (HIV-1) in cultured human blood monocyte-derived macrophages. These compounds also inhibit the in vitro activities of the HIV-1 Vpu protein and might represent lead compounds for a new class of anti-HIV-1 drugs.
引用
收藏
页码:2325 / 2330
页数:6
相关论文
共 50 条
  • [1] Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication
    Berthoux, L
    Péchoux, C
    Darlix, JL
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (12) : 10000 - 10009
  • [2] Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes macrophages
    ThumannSchweitzer, C
    Gosselin, G
    Perigaud, C
    Benzaria, S
    Girardet, JL
    Lefebvre, I
    Imbach, JL
    Kirn, A
    Aubertin, AM
    [J]. RESEARCH IN VIROLOGY, 1996, 147 (2-3): : 155 - 163
  • [3] AMINOSUGAR DERIVATIVES AS POTENTIAL ANTI-HUMAN IMMUNODEFICIENCY VIRUS AGENTS
    KARPAS, A
    FLEET, GWJ
    DWEK, RA
    PETURSSON, S
    NAMGOONG, SK
    RAMSDEN, NG
    JACOB, GS
    RADEMACHER, TW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) : 9229 - 9233
  • [4] FAILURE OF DIDEOXYNUCLEOSIDES TO INHIBIT HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION IN CULTURED HUMAN MACROPHAGES
    RICHMAN, DD
    KORNBLUTH, RS
    CARSON, DA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04): : 1144 - 1149
  • [5] New anti-human immunodeficiency virus type 1 6-aminoquinolones:: Mechanism of action
    Parolin, C
    Gatto, B
    Del Vecchio, C
    Pecere, T
    Tramontano, E
    Cecchetti, V
    Fravolini, A
    Masiero, S
    Palumbo, M
    Palù, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) : 889 - 896
  • [6] Anti-human immunodeficiency virus-type 1 activity of constituents fromJuglans mandshurica
    Byung Sun Min
    Hyeong Kyu Lee
    Sang Myung Lee
    Young Ho Kim
    Ki Hwan Bae
    Toru Otake
    Norio Nakamura
    Masao Hattori
    [J]. Archives of Pharmacal Research, 2002, 25 : 441 - 445
  • [7] Neuroprotective and anti-human immunodeficiency virus, activity of minocycline
    Zink, MC
    Uhrlaub, J
    DeWitt, J
    Voelker, T
    Bullock, B
    Mankowski, J
    Tarwater, P
    Clements, J
    Barber, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (16): : 2003 - 2011
  • [8] ANTI-HUMAN IMMUNODEFICIENCY VIRUS PHENOLICS FROM LICORICE
    HATANO, T
    YASUHARA, T
    MIYAMOTO, K
    OKUDA, T
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1988, 36 (06) : 2286 - 2288
  • [9] Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-τ in human macrophages
    Rogez-Kreuz, C
    Manéglier, B
    Martin, M
    Dereuddre-Bosquet, N
    Martal, J
    Dormont, D
    Clayette, P
    [J]. INTERNATIONAL IMMUNOLOGY, 2005, 17 (08) : 1047 - 1057
  • [10] Exosomes Transport Anti-Human Immunodeficiency Virus Factors from Human Cervical Epithelial Cells to Macrophages
    Xu, Xi-Qiu
    Zhang, Biao
    Guo, Le
    Liu, Yu
    Meng, Feng-Zhen
    Wang, Xu
    Hu, Wen-Hui
    Khan, Adil I.
    Ho, Wen-Zhe
    [J]. JOURNAL OF INNATE IMMUNITY, 2021, 13 (05) : 269 - 279